Pregnancy control in patients with systemic lupus erythematosus/antiphospholipid syndrome. Part 2: Pregnancy follow-up

• Published in: Reumatologia clinica Vol. 17; no. 3; pp. 125 - 131
• Main Authors: Rodríguez Almaraz, Esther, Sáez-Comet, Luis, Casellas, Manel, Delgado, Paloma, Ugarte, Amaia, Vela-Casasempere, Paloma, Martínez Sánchez, Nuria, Galindo-Izquierdo, Maria, Espinosa, Gerard, Marco, Beatriz, Martínez López, Juan Antonio, Robles, Angel, Martínez-Taboada, Victor, Bartha, Jose Luis, Ruiz-Irastorza, Guillermo
• Format: Journal Article
• Language: English; Spanish
• Published: Spain 01.03.2021
• Subjects: Lactancia; Pregnancy; Puerperio; Síndrome antifosfolípido; Systemic lupus erythematosus; Embarazo; Lactation; Anticoncepción; Contraception; Puerperium; Antiphospholipid syndrome; Lupus eritematoso sistémico
• ISSN: 1885-1398; 2173-5743
• DOI: 10.1016/j.reuma.2019.09.003

In order to agree on the fundamental aspects related to the management of pregnancy in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), the Spanish Societies of Gynaecology and Obstetrics, Internal Medicine and Rheumatology set up a working group for the preparation of three consensus documents. Each of the Scientific Societies involved proposed five representatives based on their experience in the field of pregnancy control in patients with autoimmune diseases. The recommendations were developed following the Delphi methodology. This second document contains the recommendations regarding the management of pregnancy in women with SLE and APS, including complications such as lupus activity, congenital heart block, thrombotic and obstetric manifestations of APS and placental vascular disease. These multidisciplinary recommendations are considered decision-making tools for clinicians involved in the care of patients with SLE/APS during pregnancy.